Monica Gandhi, MD, MPH, talks meningitis vaccination & prevention strategies, high-risk populations, vaccination coverage, & ...

Nirsevimab immunization effectively decreases the risk for RSV-related LRTI hospitalizations in an infant's first year.

Influenza mortality increased among US children over 25 years despite declines in other vaccine-preventable deaths.

Integrating community pharmacies into the HIV prevention landscape offers accessible, disease-agnostic entry points for PrEP ...

A mobile retail pharmacy and clinic model in Connecticut improves HIV care and substance use treatment for vulnerable ...

A large-scale testing initiative identified patients in the Puerto Rican correctional system with positive results for HIV ...

Long-term fumarate therapy for multiple sclerosis, compared with anti-CD20 therapy, is linked to a reduced risk for infection.

Ceftazidime-avibactam therapy yields a high clinical response rate in patients with MDR Gram-negative pneumonia in routine practice.

Dr Marissa Robinson discusses structural barriers to HIV PrEP access and strategies to enhance health equity in care delivery ...

Updated BNT162b2 KP.2 vaccination reduces COVID-19 hospitalizations and ED visits in immunocompetent adults regardless of risk status.

Real-world data demonstrate that nirsevimab and maternal vaccination protect infants against severe RSV outcomes.

Previous STI history is linked to increased current PrEP use, though uptake disparities remain across patient demographic ...